Teva announces FDA approval, commercial launch of generic ARIMIDEX

[News]

Teva Pharmaceutical Industries Ltd. announced today U.S. Food and Drug Administration (FDA) approval and commercial launch of Anastrozole Tablets 1 mg, the Company's generic version of AstraZeneca's ARIMIDEX®.

More... (http://www.news-medical.net/news/20100629/Teva-announces-FDA-approval-commercial-launch-of-generic-ARIMIDEX.aspx)